News
Dr. George Tidmarsh: FDA Declared Substances Like Talc Were Safe In The 1970s, Never Reexamined Them
Dr. George Tidmarsh, physician, scientist, and biotech CEO, joins Jerry Rogers on "The Business of America" podcast to ...
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
A U.S. bankruptcy court judge has denied Johnson & Johnson's settlement plan related to baby powder containing talc, providing another setback in the company's efforts to resolve the matter.
J&J then proposed the $8.9bn settlement in early 2023 to resolve the claims. This proposal would have ended both current and future lawsuits related to J&J’s talc-based products.
J&J, with a market capitalisation of $400bn, has struggled to convince judges to allow it to resolve its talc liability through bankruptcy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results